Searched for
PHARMA
India, S African customs union ink terms to launch trade talksIndia and the Southern African Customs Union have commenced discussions by signing Terms of Reference for a trade agreement. Expected to fi...- Marksans Pharma shares rally over 9% after Q1 profit spikes 174% YoY to Rs 159 croreMarksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a r...
- Sun will require HC nod for Semaglutide tablet launchThe Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisk...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities declined as rising crude prices and a weaker rupee weighed on sentiment. Sensex fell 388 points and Nifty 112 points, while...
- Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...
- Doctors' safety alert led to Sun Pharma eye drop recallSun Pharma recalled eleven eyecare products after an eye specialists' body issued a safety alert. This alert warned about bacterial contami...
- Medical devices are not pharma products, companies say while opposing Draft BillIndia’s medical device industry and healthcare groups have opposed the draft Drugs, Medical Devices and Cosmetics Bill, 2026, arguing that ...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Ahmedabad's special ops seizes 5,050 bottles of Codeine syrup, books pharma firmsAhmedabad SOG seized over five thousand bottles of cough syrup. A case was registered under the NDPS Act for illegal supply. The investigat...
- Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
- Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...
- Govt plans new drugs law to overhaul pharma, medical device regulationThe government is set to replace the 1940 Drugs and Cosmetics Act with a new law covering drugs, medical devices and cosmetics. The draft b...
- Delhi HC seeks response on Natco's patent challenge pleaThe Delhi High Court is reviewing Natco Pharma's challenge to a breast cancer drug patent. Natco alleges Novartis and Astex secured two pat...
- Stock Radar: Concord Biotech stock showing signs of rebound after falling over 20% from highs; time to buy?Concord Biotech stock shows a breakout from a seven-month consolidation phase. Experts suggest buying the stock for a target above 1,500 le...
- India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...
- Buy, Sell or Hold: Morgan Stanley maintains buy on Maruti Suzuki; Citi retains buy on Sun PharmaGlobal brokerages remained selective on large-cap stocks following the latest round of quarterly earnings, with Citi reiterating its bullis...
- MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipelineSun Pharma's June quarter results met analyst expectations, signaling future growth. The company is expanding its specialty and innovative ...
- Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...
- Piramal Pharma to focus on policy, not Trump tariff tweets: Nandini PiramalPiramal Pharma will focus on policy actions amid tariff concerns. Its global manufacturing network offers a significant advantage. The comp...
Load More
